Multimorbidity and polypharmacy: a risk factor for older patients
Keywords:
Multimorbidity, polypharmacy, older patientsAbstract
Invited commentary on Letter: Acta Biomed 2022; Vol. 93, N. 2: e2022136 DOI 10.23750/abm.v93i2.12855
https://mattioli1885journals.com/index.php/actabiomedica/article/view/12855
References
Linea Guida Intersocietaria per la gestione della comorbilità e della multipatologia .ISTITUTO SUPERIORE DI SANITÀ Italy, , 4 Giugno 2021
Polypharmacy Guidance Realistic Prescribing NHS Scotland 2018. https://www.therapeutics.scot.nhs.uk 2018/04
Budnitz DS, et el Emergency hospitalizations for adverse drug events in older Americans. N. E. J. M. 2011;365(21):2002-12
htpp://DEPRESCRIBING.ORG Optimizing medication use
Rochon P.A. et al, Polypharmacy, inappropriate prescribing, and deprescribing in older people: through a sex and gender lens Lancet Healthy Longev 2021; 2: e290–300
International Association of Gerontology and Geriatrics European Region, Ex Com.2003
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Domenico Cucinotta
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
How to Cite
